USD 850 million
Breast Biopsy Market Size, Share, Growth Analysis, By Type(Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy), By Application(Hospitals and clinics, diagnostic centres) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2467 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
61 |
Figures:
75
Breast Biopsy Market Insights
Global Breast Biopsy Market size was valued at USD 850 million in 2022 and is poised to grow from USD 921.40 million in 2023 to USD 1756.64 million by 2031, growing at a CAGR of 8.4% during the forecast period (2024-2031).
The global breast biopsy market is a dynamic and rapidly growing sector within the healthcare industry. It encompasses a range of diagnostic procedures that are used to assess and analyze breast tissue for the presence of abnormalities or potential breast cancer. The market is driven by various factors, including the increasing incidence of breast cancer worldwide, rising awareness about early detection and diagnosis, technological advancements in imaging modalities and biopsy techniques, and growing demand for minimally invasive procedures. The market offers a diverse range of biopsy methods, including core needle biopsy, vacuum-assisted biopsy, fine needle aspiration, and surgical biopsy. Additionally, there is a rising trend toward the adoption of image-guided biopsy procedures, such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies, as they offer improved accuracy and precision. Furthermore, the market is witnessing the development of innovative biopsy devices and systems, including automated biopsy guns, handheld biopsy devices, and stereotactic biopsy systems, which enhance procedural efficiency and patient comfort. Geographically, North America dominated the global market, attributed to the high prevalence of breast cancer, well-established healthcare infrastructure, and favorable reimbursement policies. However, emerging economies in Asia-Pacific and Latin America are expected to witness significant growth in the coming years due to increasing healthcare expenditure, improving healthcare facilities, and rising awareness about breast cancer screening. In conclusion, the global breast biopsy market is poised for substantial growth as healthcare systems focus on early detection and accurate diagnosis of breast cancer, leading to improved patient outcomes and reduced mortality rates.
US Breast Biopsy Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Vacuum-assisted biopsy
Fastest Growth
Vacuum-assisted biopsy
Growth Rate
8.4% CAGR
Global Breast Biopsy Market ($ Bn)
Country Share for North America Region (%)
Global Breast Biopsy Market By Type ($ Bn)
Global Breast Biopsy Market By Type (%)
To get more reports on the above market click here to Buy The Report
Breast Biopsy Market Segmental Analysis
The Global Breast Biopsy Market is segmented by type, application, and region. Based on type, the market can be segmented into Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy. Based on application, the market is segmented into Hospitals and clinics, diagnostic centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Breast Biopsy Market Analysis by Type
The dominant segment in the global breast biopsy market is vacuum-assisted biopsy. Vacuum-assisted biopsy has gained significant traction due to its advantages over other biopsy methods, including higher tissue yield, better sampling accuracy, and reduced procedural time. This technique involves the use of a vacuum-powered device to extract multiple tissue samples, enabling comprehensive sampling of suspicious lesions. Vacuum-assisted biopsy is widely adopted in clinical practice and is considered a standard procedure for both diagnostic and minimally invasive therapeutic purposes.
The fastest-growing segment in the global breast biopsy market is core needle biopsy. Core needle biopsy has witnessed a surge in demand due to its minimally invasive nature, higher diagnostic accuracy, and reduced patient discomfort compared to traditional surgical biopsies. This technique involves the use of a larger, hollow-core needle to obtain a tissue sample from the breast lesion, allowing for a more comprehensive analysis. Core needle biopsy offers several benefits, such as shorter recovery time, lower cost, and minimal scarring, contributing to its increasing adoption by healthcare professionals and patients alike. The growing preference for less invasive procedures and the continuous development of advanced core needle biopsy devices are driving the rapid growth of this segment in the market.
Breast Biopsy Market Analysis by Application
The dominant segment in the global breast biopsy market based on application is hospitals and clinics. Hospitals and clinics serve as primary healthcare settings where breast biopsies are routinely performed. These facilities are equipped with advanced imaging technologies, such as mammography, ultrasound, and MRI, which aid in the detection and localization of breast abnormalities. Moreover, hospitals and clinics have skilled healthcare professionals, including radiologists, pathologists, and surgeons, who are trained in performing breast biopsies and interpreting the results. The availability of comprehensive healthcare services, multidisciplinary care teams, and the ability to provide a wide range of treatment options contribute to the prominence of hospitals and clinics in the breast biopsy market.
The fastest-growing segment in the global breast biopsy market based on application is diagnostic centers. Diagnostic centers are specialized healthcare facilities that focus on diagnostic imaging and laboratory services. These centers often collaborate with referring physicians or healthcare institutions to perform breast biopsies as part of their diagnostic services. The increasing demand for efficient and specialized diagnostic services, coupled with the rising prevalence of breast cancer, has led to the rapid growth of diagnostic centers in the breast biopsy market. Diagnostic centers offer convenience, faster turnaround times, and cost-effective solutions for patients seeking breast biopsy procedures. The trend towards outpatient care, coupled with the expanding network of diagnostic centers, is driving the growth of this segment in the market.
Global Breast Biopsy Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Breast Biopsy Market Regional Insights
North America dominated the global breast biopsy market based on region. North America holds a significant share in the market due to various factors, including a high prevalence of breast cancer, well-established healthcare infrastructure, and favorable reimbursement policies. The region has witnessed substantial investments in advanced medical technologies, research and development activities, and robust healthcare systems, contributing to the dominance of North America in the breast biopsy market. Moreover, the presence of key market players and increasing awareness about early detection and screening programs further support the growth of the market in this region.
The fastest-growing segment in the global breast biopsy market based on region is Asia Pacific. Asia Pacific region is experiencing rapid market growth owing to several factors, such as a large population base, increasing healthcare expenditure, and rising awareness about breast cancer screening. Additionally, governments in countries like China and India are implementing initiatives to improve healthcare infrastructure and provide accessible and affordable healthcare services, which includes breast cancer screening and diagnosis. Moreover, advancements in healthcare technologies, growing medical tourism, and the rising demand for minimally invasive procedures are contributing to the fast-paced growth of the breast biopsy market in the Asia Pacific region.
Global Breast Biopsy Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Breast Biopsy Market Dynamics
Breast Biopsy Market Drivers
Increasing incidence of breast cancer
- One key driver for the Global Breast Biopsy Market is the increasing incidence of breast cancer worldwide. Breast cancer is one of the most common cancers globally, and its prevalence has been steadily rising over the years. This growing burden of breast cancer has led to an increased emphasis on early detection, diagnosis, and treatment, driving the demand for breast biopsy procedures. The need for accurate and reliable diagnostic techniques to identify breast abnormalities and enable timely intervention has significantly contributed to the growth of the breast biopsy market.
Breast Biopsy Market Restraints
Potential for false-negative or false-positive results
- A notable restraint for the Global Breast Biopsy Market is the potential for false-negative or false-positive results. While breast biopsies play a crucial role in diagnosing breast cancer, there is a possibility of erroneous results. False-negative results may occur when the biopsy fails to detect cancerous cells, leading to a delayed or missed diagnosis. On the other hand, false-positive results can cause unnecessary anxiety, additional testing, and potentially invasive procedures for patients. These limitations in diagnostic accuracy can undermine confidence in the reliability of breast biopsy procedures and pose challenges to healthcare providers and patients in making informed treatment decisions.
Request Free Customization of this report to help us to meet your business objectives.
Breast Biopsy Market Competitive Landscape
The global breast biopsy market is characterized by intense competition and the presence of several market players. These players primarily focus on product development, technological advancements, strategic collaborations, and mergers and acquisitions to gain a competitive edge. The market is witnessing a significant emphasis on the development of advanced biopsy devices and systems, including automated biopsy guns, handheld biopsy devices, and image-guided biopsy systems. Furthermore, players are investing in research and development activities to introduce innovative and minimally invasive biopsy techniques that offer enhanced precision and accuracy. Additionally, marketing initiatives, expansion into untapped markets, and a strong distribution network are key strategies adopted by market players to strengthen their market position and cater to the growing demand for breast biopsy procedures.
Breast Biopsy Market Top Player’s Company Profiles
- Ethicon Endo Surgery (US)
- C. R. Bard, Inc. (US)
- Leica Biosystems Nussloch GmbH (Germany)
- Hologic Inc. (US)
- Intact Medical Corporation (US)
- Galini SRL (Italy)
- Argon Medical Devices (US)
- Cook Medical Incorporated (US)
- Medtronic plc (Ireland)
- Devicor Medical Products, Inc. (US)
- Carestream Health, Inc. (US)
- Planmed Oy (Finland)
- NIPRO Medical Corporation (Japan)
- Seno Medical Instruments, Inc. (US)
- Scion Medical Technologies LLC (US)
- Biopsybell S.r.l. (Italy)
- STERYLAB S.r.l. (Italy)
- Medicon Hellas S.A. (Greece)
Breast Biopsy Market Recent Developments
- In January 2023, Hologic Inc. Receives FDA Approval for New Breast Biopsy System: Hologic Inc., a leading company in the breast biopsy market, announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its innovative Affirm Prone Biopsy System. The system offers high-precision, minimally invasive breast biopsies, aiming to provide improved patient comfort and enhanced diagnostic accuracy.
- In March 2022, C. R. Bard, Inc. Announces Acquisition by BD: C. R. Bard, Inc., a prominent player in the breast biopsy market, finalized its acquisition by Becton, Dickinson and Company (BD). This acquisition strengthens BD's presence in the sector by incorporating C. R. Bard's extensive range of biopsy devices and solutions. The merger aims to offer comprehensive diagnostic and treatment options for breast cancer patients while driving further innovation and market expansion.
- In August 2021, Ethicon Endo Surgery Collaborates with Research Institutions for Breast Biopsy Research: Ethicon Endo Surgery, a subsidiary of Johnson & Johnson, announced its collaboration with renowned research institutions to advance the development of minimally invasive breast biopsy techniques and technologies. This partnership highlights Ethicon's commitment to innovation and improving patient outcomes in the breast biopsy market, with a focus on enhancing accuracy, efficiency, and patient experience in biopsy procedures.
Breast Biopsy Key Market Trends
- One key market trend in the global breast biopsy market is the increasing adoption of image-guided biopsy techniques. Image-guided biopsies, such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies, have gained significant popularity in recent years. These techniques utilize advanced imaging modalities to precisely target and sample suspicious breast lesions, leading to improved accuracy and reduced invasiveness compared to traditional biopsy methods. The use of real-time imaging guidance allows for better visualization of the target area, resulting in enhanced diagnostic yield and minimizing the need for repeated procedures. The growing trend towards image-guided biopsies reflects the industry's focus on improving the accuracy and efficiency of breast biopsy procedures while prioritizing patient comfort and reducing procedural risks.
Breast Biopsy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global breast biopsy market analysis, the market is a rapidly growing sector within the healthcare industry. It is driven by factors such as the increasing incidence of breast cancer worldwide, rising awareness about early detection, and technological advancements in biopsy techniques. The market offers a range of biopsy methods, with vacuum-assisted biopsy being the dominant segment and core needle biopsy being the fastest growing. Hospitals and clinics are the dominant application segment, while diagnostic centers are the fastest growing. North America holds a significant market share, while the Asia Pacific region is experiencing rapid growth. Key drivers include the rising incidence of breast cancer, while a key restraint is the potential for false-negative or false-positive results. The competitive landscape is characterized by intense competition, with companies focusing on product development and strategic collaborations. Key market trends include the increasing adoption of image-guided biopsy techniques for improved accuracy and patient comfort. Overall, the global market is poised for substantial growth as healthcare systems emphasize early detection and accurate diagnosis of breast cancer.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 850 million |
| Market size value in 2031 | USD 1756.64 million |
| Growth Rate | 8.4% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Breast Biopsy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Breast Biopsy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Breast Biopsy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Breast Biopsy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Breast Biopsy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Breast Biopsy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
